210 материалов по теме, собраны автоматически из проверенных источников
Major Milestone in Colon Cancer: FDA Approves Atezolizumab Adjuvant Combination - Alliance for Clinical Trials in Oncology Oncodaily
Tecentriq Plus Chemotherapy Wins Approval for Stage III dMMR Colon Cancer After Halving Recurrence or Death Risk Medical Daily
In Britain, 32 patients had no bowel cancer recurrence for 33 months — ScienceDaily UA.NEWS
Bowel cancer “melted away” after immunotherapy, then stayed away ScienceDaily
Precision Medicine: From Promise to Practice in Colorectal Cancer Care – GCCA Oncodaily
Рак кишечника: новый метод лечения вдвое снизил риск возвращения болезни Газета Балаково
Phase III trial of cadonilimab begins in perioperative colon cancer The Clinical Trial Vanguard
Aspirin Did Not Prevent Colorectal Cancer Return After Liver Metastasis Treatment Cure Today
Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important mechanism behind immune evasion in metastatic colorectal cancer (mCRC). Their findings challenge a 30-year-old theory about…
FDA Approves Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer Oncology News Central
FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair News-Medical
The FDA has approved atezolizumab plus chemotherapy as an adjuvant treatment for patients aged 2 years and older with stage III mismatch repair deficient colon cancer. Atezolizumab (Tecentriq, Genentech) in combination with a fluoropyrimidine and oxaliplatin is now the first adjuvant immunotherapy regimen approved for…
FDA Approves Adjuvant Atezolizumab for Certain Colon Cancers MedPage Today
FDA Approved Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer Oncodaily
FDA OKs new colon cancer treatment based on Mayo Clinic research KIMT